Advocate Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Advocate Group's JNJ Position: Q3 2026 in Review
Advocate Group reduced its Johnson & Johnson (JNJ) stake by 3.8% in Q3 2026, selling an estimated $615K and leaving 59,079 shares worth $15.6M. The position accounts for 2.42% of the portfolio, ranked #6.
Advocate Group first reported a position in JNJ in Q2 2022 and has held it in 18 quarters since. The position peaked at $15.8M in Q1 2026. 2,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.
- Advocate Group held 59,079 shares of Johnson & Johnson worth $15.6M as of Q3 2026.
- Advocate Group sold 2,333 Johnson & Johnson shares in Q3 2026, an estimated $615K.
- Johnson & Johnson made up 2.42% of Advocate Group's portfolio in Q3 2026, its #6 holding.
- Advocate Group first reported a position in Johnson & Johnson in Q2 2022 and has held it in 18 quarters since.
- Advocate Group's Johnson & Johnson position peaked at $15.8M in Q1 2026.
- 2,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.
Based on Advocate Group's 13F filing for Q3 2026, filed 19 Oct 2026.